What is the safest analgesic for a pregnant woman with ankylosing spondylitis?

Safest Painkiller in Pregnancy for Ankylosing Spondylitis

For pregnant women with ankylosing spondylitis, ibuprofen is the safest analgesic option during the first and second trimesters (up to 28 weeks), used at the lowest effective dose for short periods (7-10 days), while acetaminophen (paracetamol) is the only safe option throughout all trimesters including the third trimester. 1

First-Line Analgesic Strategy

First and Second Trimester (Up to Week 28)

• Ibuprofen is the preferred NSAID with the most reassuring safety data, followed by diclofenac 1
• Use the lowest effective dose for short duration (7-10 days maximum) to minimize fetal exposure 1
• NSAIDs show no evidence of increased miscarriage risk or teratogenicity in early pregnancy 1
• Short-term use in the second trimester (7-10 days) does not pose substantial fetal risks 1

Third Trimester (After Week 28)

• All NSAIDs must be discontinued after gestational week 28 due to increased risks of:
  • Oligohydramnios (reduced amniotic fluid)
  • Premature closure or narrowing of the fetal ductus arteriosus 1
• Switch to acetaminophen/paracetamol as the only safe analgesic option for mild-to-moderate pain throughout all pregnancy stages 2

Important Caveats and Pitfalls

Preconception Considerations

• Women trying to conceive should avoid continuous NSAID use around ovulation, as NSAIDs can induce luteinized unruptured follicle (LUF) syndrome and reduce fertility 1
• Consider discontinuing NSAIDs if difficulty conceiving

COX-2 Inhibitors

• Avoid COX-2 selective inhibitors (celecoxib, etoricoxib) as safety data are limited compared to traditional NSAIDs 1

Alternative and Adjunctive Options

Low-Dose Corticosteroids

• Prednisone/prednisolone can be used if needed to control active disease 1
• Target maintenance dose ≤5 mg/day when possible 1
• Higher doses carry risks of gestational diabetes, preterm birth, and maternal infections 1
• Not associated with increased major birth defects 1

Disease-Modifying Therapy

• Sulfasalazine can be continued at doses up to 2 g/day throughout pregnancy with mandatory folic acid supplementation 1
• TNF inhibitors are safe for controlling disease activity during pregnancy 3, 4

Clinical Algorithm

1. Before 28 weeks: Use ibuprofen at lowest effective dose for ≤7-10 days when needed
2. After 28 weeks: Switch to acetaminophen only
3. If inadequate pain control: Add low-dose prednisone (≤5 mg/day) rather than continuing NSAIDs
4. For disease activity control: Continue or initiate sulfasalazine or TNF inhibitors as appropriate

The 2025 EULAR guidelines 1 provide the most current evidence-based framework, emphasizing that the critical cutoff is gestational week 28, after which NSAID-related fetal complications increase substantially. This represents a shift from older recommendations and reflects updated understanding of prostaglandin-dependent fetal physiology in late pregnancy.